Mingfang Wu
- Molecular Biology
- Pharmaceutical Science top 5%
- Biomaterials top 10%
- Biomedical Engineering
- Food Science top 10%
- Topics
- Nanoparticle-Based Drug Delivery (6 papers)Natural product bioactivities and synthesis (4 papers)Nanoplatforms for cancer theranostics (4 papers)
In The Last Decade
Mingfang Wu
27 papers receiving 568 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 156
- Pharmaceutical Science 113
- Biomaterials 111
- Biomedical Engineering 93
- Food Science 83
Countries citing papers authored by Mingfang Wu
This map shows the geographic impact of Mingfang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfang Wu more than expected).
Fields of papers citing papers by Mingfang Wu
This network shows the impact of papers produced by Mingfang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfang Wu. The network helps show where Mingfang Wu may publish in the future.
Co-authorship network of co-authors of Mingfang Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Mingfang Wu. A scholar is included among the top collaborators of Mingfang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingfang Wu. Mingfang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 11 | |
| 4 | 2 | |
| 5 | 8 | |
| 6 | 39 | |
| 7 | 12 | |
| 8 | 20 | |
| 9 | 25 | |
| 10 | 45 | |
| 11 | 25 | |
| 12 | 26 | |
| 13 | 17 | |
| 14 | 18 | |
| 15 | 27 | |
| 16 | 76 | |
| 17 | 23 | |
| 18 | 17 | |
| 19 | 4 | |
| 20 | A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release. | 5 |
About Mingfang Wu
Mingfang Wu is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 27 papers that have together received 577 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Natural product bioactivities and synthesis (4 papers) and Nanoplatforms for cancer theranostics (4 papers). The work is most often cited by research in Pharmaceutical Science (113 citations), Molecular Medicine (47 citations) and Biomaterials (111 citations). Mingfang Wu has collaborated with scholars based in China, Slovakia and Canada. Frequent co-authors include Xiuhua Zhao, Yiping Deng, Weiwei Wu, Ziqi Feng, Yuangang Zu, Chen Zhong, Lingling Wang, Chang Zu, Lu Wang and Bolin Lian. Their work appears in journals such as Cancer Research, International Journal of Pharmaceutics and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.